Halogen interactions in protein-ligand complexes: Implications of halogen bonding for rational drug design

Journal of Chemical Information and Modeling

Volumn 53, Issue 11, 2013, Pages 2781-2791

  Sirimulla, Suman ^a   Bailey, Jake B ^a   Vegesna, Rahulsimham ^b   Narayan, Mahesh ^c  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; AMINO ACIDS; AROMATIC COMPOUNDS; COMPLEXATION; LIGANDS; PROTEINS; VAN DER WAALS FORCES;

ACHIRAL AMINO ACIDS; ELECTRON-RICH AROMATICS; HALOGENATED LIGANDS; PHARMACEUTICAL APPLICATIONS; PROTEIN-LIGAND COMPLEXES; RATIONAL DRUG DESIGNS; SIDE-CHAIN INTERACTIONS; VAN DER WAALS RADIUS;

HALOGEN COMPOUNDS;

AMINO ACID; LEWIS BASE; LIGAND; NITROGEN; OXYGEN; PROTEIN; SULFUR;

ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DESIGN; ELECTRON; KINETICS; PROTEIN DATABASE; THERMODYNAMICS;

AMINO ACIDS; DATABASES, PROTEIN; DRUG DESIGN; ELECTRONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; LEWIS BASES; LIGANDS; NITROGEN; OXYGEN; PROTEINS; SULFUR; THERMODYNAMICS;

EID: 84888630744     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci400257k     Document Type: Review

References (34)

1. Tubinger, U. Halogen Bonding Helps Design New Drugs. http://www. sciencedaily.com/releases/2012/06/120605121639.htm (accessed February 26, 2012).
2. Lu, Y.; Shi, T.; Wang, Y.; Yang, H.; Yan, X.; Luo, X.; Jiang, H.; Zhu, W. Halogen bonding: A novel interaction for rational drug design? J. Med. Chem. 2009, 52, 2854-2862
3. Hernandez, M.; Cavalcanti, S.; Moreira, D.; Asevedo, W. J.; Leite, A. Halogen atoms in the modern medicinal chemistry: Hints of the drug design Curr. Drug Targets 2010, 3, 303-315
4. Kortagere, S.; Ekins, S.; Welsh, W. J. Halogenated ligands and their interactions with amino acids: Implications for structure-activity and structure-toxicity relationships J. Mol. Graphics Modell. 2008, 27, 170-177
5. Jorgensen, W. J.; Schyman, P. Treatment of halogen bonding in the OPLS-AA force field: Application to potent anti-HIV agents J. Chem. Theory Comput. 2012, 8, 3895-3901
6. Small Changes for Big Improvement: Halogen Bond and Drug Discovery. http://www.sciencedaily.com/releases/2013/01/130118064729.htm (accessed April 24, 2013).
7. Rendine, S.; Pieraccini, S.; Forni, A.; Sironi, M. Halogen bonding in ligand-receptor systems in the framework of classical force fields Phys. Chem. Chem. Phys. 2011, 13, 19508-19516
8. Bonnefous, C.; Payne, J. E.; Roppe, J.; Zhuang, H.; Chen, Z.; Symons, K. T.; Nguyen, P. M.; Sablad, M.; Rozenkrants, N.; Zhang, Y.; Wang, L.; Severance, D.; Walsh, J. P.; Yazdani, N.; Shiau, A. K.; Noble, S. A.; Rix, P.; Rao, T. S.; Hassig, C. A.; Smith, N. D. Nitric oxide synthase (iNOS) inhibitor development canidate KD7332, Part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models J. Med. Chem. 2009, 52, 3047-3062
9. Parisini, E.; Metrangolo, P.; Pilati, T.; Resnati, G.; Terraneo, G. Halogen bonding in halocarbon-protein complexes: A structural survey Chem. Soc. Rev. 2011, 40, 2267-2278
10. Buchini, S.; Buschiazzo, A.; Withers, S. G. A new generation of specific Trypanosoma crizi trans -sialidase inhibitors Agnew. Chem., Int. Ed. 2008, 47, 2700-2703
11. Auffinger, P.; Hays, F.; Westhof, E.; Ho, P. Halogen bonds in biological molecules Proc. Natl. Acad. Sci. U.S.A 2004, 101, 16789-16794
12. Hardegger, L. A.; Kuhn, B. S.; Anselm, L.; Ecabert, R.; Stihle, M.; Gsell, B.; Thoma, R.; Diez, J.; Benz, J.; Plancher, J. M.; Hartmann, G.; Banner, D. W.; Haap, W.; Diederich, F. Systematic investigation of halogen bonding in protein-ligand interactions Agnew. Chem., Int. Ed. 2011, 50, 314-318
13. De Paulis, T.; Hemstapat, K.; Chen, Y.; Zhang, Y.; Saleh, S.; Alagille, D.; Baldwin, R.; Tamagnan, G.; Conn, P. Substituent effects of N-(1,3-diphenyl-1H-pyrazpn-5-yl)benzamides on positive allosteric modulation of the metabolic glutamate-5 receptor in rat cortical astrocytes J. Med. Chem. 2006, 49, 3332-3344
14. Himmel, D.; Das, K.; Clark, A.; Hughes, S.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C.; Grierson, D.; Arnold, E. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains J. Med. Chem. 2005, 48, 7582-7591
15. Fedorov, O.; Huber, K.; Eisenreich, A.; Filippakopoulos, P.; King, O.; Bullock, A. N.; Szklarczyk, D.; Jensen, L. J.; Fabbro, D.; Trappe, J.; Rauch, U.; Bracher, F. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing Chem. Biol. 2011, 18, 67-76
16. Bollini, M.; Domaoal, R. A.; Thakur, V. V.; Gallardo-Macias, R.; Spasov, K. A.; Anderson, K. S.; Jorgensen, W. L. Computationally-guided optimization of a dockinghit to yield catechol diethers as potent anti-HIV agents J. Med. Chem. 2011, 54, 8582-8591
17. Xu, Z.; Liu, Z.; Chen, T.; Chen, T. T.; Wang, Z.; Tian, G.; Shi, J.; Wang, X.; Lu, Y.; Yan, X.; Wang, G.; Jiang, H.; Chen, K.; Wang, S.; Xu, Y.; Shen, J.; Zhu, W. Utilization of halogen bond in lead optimization: A case study of rational drug design of potent phosphodiesterase type 5 (PDE5) inhibitors J. Med. Chem. 2011, 54, 5607-5611
18. Matter, H.; Nazare, M.; Gussregen, S.; Will, D. W.; Schreuder, H.; Bauter, A.; Urmann, M.; Ritter, K.; Wagner, M.; Wehner, V. Evidence for C-Cl/C-Br⋯ π interactions as an important contribution to protein-ligand binding affinity Agnew. Chem., Int. Ed. 2009, 48, 2911-2916
19. Wilchen, R.; Liu, X.; Zimmermann, M. O.; Rutherford, T. J.; Fersht, A. R.; Joerger, A. C.; Boeckler, F. M. Halogen-enriched fragment libraries as leads for drug rescue of mutant p53 J. Am. Chem. Soc. 2012, 134, 6810-6818
20. Politzer, P.; Murray, J. S.; Clark, T. An electrostatically-driven highly directional noncovalent interaction Phys. Chem. Chem. Phys. 2010, 12, 7748-7757
21. Clark, T.; Hennemann, M.; Murray, J.; Politzer, P. Halogen bonding: The sigma-hole J. Mol. Model. 2007, 13, 291-297
22. Desiraju, G. R.; Ho, P. S.; Kloo, L.; Legon, A. C.; Marquardt, R.; Metrangolo, P.; Poloitzer, P. A.; Resnati, G.; Rissanen, K. Definition of the Halogen Bond. http://pac.iupac.org/publications/pac/pdf/2013/pdf/8508x1711.pdf (accessed February 25, 2013).
23. Kemsley, J. N. Hydrogen Bond Reformation. http://cen.acs.org/articles/88/ i47/Hydrogen-Bond-Reformulation.html (accessed February 27, 2013).
24. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr., J. A.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision A.1; Gaussian, Inc.: Wallingford CT, 2009.
25. Pavan, M. S.; Prasad, K. D.; Row, T. N. G. Halogen bonding in fluorine: Experimental charge density study on intermolecular F⋯F and F⋯S donor-acceptor contacts Chem. Commun. 2013, 49, 7558-7560
26. Politzer, P.; Lane, P.; Monice, C. C.; Ma, Y.; Murray, J. S. An overview of halogen bonding J. Mol. Model. 2007, 13, 305-311
27. Clark, T. σ-Holes Comput. Mol. Sci. 2013, 3, 13-20
28. Lu, J.; Zhang, B.; Deng, Q.; Wang, J.; Lu, Y.; Zhu, W. The nature and magnitude of specific halogen bonds between iodo-perfluorobenzene and heterocyclic systems Int. J. Quantum Chem. 2010, 111, 2352-2358
29. Wilchen, R.; Zimmermann, M.; Lange, A.; Zahn, S.; Boeckler, F. Using halogen bonds to address the protein backbone: A systematic evaluation J. Comput.-Aided Mol. Des. 2012, 26, 935-945
30. Lu, Y.; Zou, J.; Wang, Y.; Jiang, Y.; Yu, Q. Ab initio investigation of the complexes between bromobenxene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions J. Phys. Chem. A. 2007, 111, 10781-10788
31. Wilcken, R.; Zimmermann, M.; Lange, A.; Joerger, A.; Boeckler, F. Principles and applications of halogen bonding in medicinal chemistry and chemical biology J. Med. Chem. 2013, 56, 1363-1388
32. The PyMOL Molecular Graphics System, Version 1. 5. 0. 4; Schrodinger, LLC; Portland, OR, 2012.
33. McDonald, I.; Thornton, J. Satisfying hydrogen bonding potential in proteins J. Mol. Biol. 1994, 238, 777-793
34. Voth, A.; Khuu, P.; Oishi, K.; Ho, P. Halogen bonds as orthogonal molecular interactions to hydrogen bonds Nat. Chem. 2009, 1, 74-79